Trial Profile
Comparative trial between computer-guided intravenous infusion protocol versus a standard insulin infusion algorithm versus a simple calculated infusion protocol in medical and surgical ICU [intensive care unit].
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin glulisine (Primary)
- Indications Diabetes mellitus; Hyperglycaemia
- Focus Therapeutic Use
- Sponsors Sanofi
- 27 Jan 2010 Actual number of patients (151) added as reported by ClinicalTrials.gov.
- 27 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Oct 2008 Planned end date changed from 1 Jul 2008 to 1 Dec 2008 as reported by ClinicalTrials.gov.